Teva Adds 40th Drug to Contract Pharmacy Restriction Policy

Teva added a biosimilar of AbbVie's blockbuster Humira to its list of products included in its 340B contract pharmacy restrictions.
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Curtis Frazier, Director, The Alinea Group

Curtis Frazier
Q: Where did you grow up?

I grew up in the Quad Cities, located on the Illinois/Iowa border. It was always interesting to meet people.

Read More »

Breaking News

Appeals Court Approves Drugmakers’ Federal 340B Contract Pharmacy Restrictions But Leaves Open Possibility of Enforcement Against Stricter Policies

A federal appeals court decided that the 340B statute does not prohibit all types of restrictions on 340B contract pharmacy use.
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Legislature Clears Contract Pharmacy Access Bill But Enforcement Measures Dropped At Last Moment

The Minnesota legislature passed a bill from state Rep. Dave Lislegard (D) to bar 340B drugmaker contract pharmacy restrictions in the state.
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ohio Senator Introduces 340B Contract Pharmacy Access Bill in State Legislature

Ohio state Sen. Bob Hackett (R) introduced a bill to bar drugmaker 340B contract pharmacy restrictions in the state.
Ohio is the latest state to consider proposed legislation that would ban drugmakers from restricting covered entities’ acquisition of 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PBM is not a 4-letter word: How an independent PBM and an integrated pharmacy strategy provides value for your organization

SPONSORED CONTENT

Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach to pharmacy and typically will separate pharmacy benefit management from pharmacy operations management. Creating an integrated pharmacy strategy can

Read More »

New Super PAC Targets GOP 340B Supporters, Takes Disputed Credit for Key West Virginia Lawmaker’s Primary Loss

A super PAC with ties to a well-funded dark money group has said it will target Republican lawmakers who support 340B legislation.
A new political action committee (PAC) targeting Republican lawmakers that support 340B legislation spent $400,000 in a key West Virginia [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk To Provide Refunds on Ozempic and Three Other Drugs to 340B Entities

Drugmaker Novo Nordisk is providing refunds to 340B covered entities on its blockbuster diabetes/weight loss drug Ozempic and three other products.
Drugmaker Novo Nordisk announced it is providing 340B covered entities 12-months-worth of refunds on four drug products including two of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Drugs Reach 18% of Outpatient Drug Sales, Says PhRMA-Backed Research; Providers Say It is Misleading

A PhRMA funded report found that 340B drugs grew to 18% of total outpatient branded drug sales in 2022. The figures were criticized by 340B providers and others as misleading.
340B drugs have steadily increased as a share of U.S. branded outpatient pharmaceutical sales and reached 18% of the total [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals Should Consider Internal Pharmacies, Selective Contracting, Says Consulting Group

Executives at a healthcare financial consulting group recommended 340B hospitals consider using in-house pharmacies.
Hospitals in the 340B program should respond to increasing drugmaker contract pharmacy restrictions by opening their own pharmacies or selectively [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live